 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/12/2024 |
$3.34 |
$3.42 |
$3.31 |
$3.41 |
5.80K | | 04/15/2024 |
$3.41 |
$3.41 |
$3.32 |
$3.36 |
21.60K | | 04/16/2024 |
$3.33 |
$3.39 |
$3.30 |
$3.35 |
7.40K | | 04/17/2024 |
$3.31 |
$3.31 |
$3.16 |
$3.19 |
16.80K | | 04/18/2024 |
$3.17 |
$3.17 |
$3.06 |
$3.07 |
9.70K |
|
|
| Acasti Pharma is a biopharmaceutical company that is focused on developing and commercializing products for rare and orphan diseases by using its drug delivery technologies. Co.'s primary drug candidate, GTX-104, is an IV formulation of nimodipine designed to treat subarachnoid hemorrhage, a rare brain disorder. Co.'s other drug candidates are: GTX-102, which is an oral-mucosal betamethasone spray for the treatment of Ataxia Telangiectasia, an orphan pediatric genetic neurodegenerative disorder in young children; and GTX-101, which is a topical bioadhesive film-forming bupivacaine spray for Postherpetic Neuralgia, which causes debilitating pain following infection by the shingles virus. | |
|
Acasti Pharma (ACST) has the following price history information. Looking back at ACST historical stock prices for the last five trading days, on April 12, 2024, ACST opened at $3.34, traded as high as $3.42 and as low as $3.31, and closed at $3.41. Trading volume was a total of 5.80K shares. On April 15, 2024, ACST opened at $3.41, traded as high as $3.41 and as low as $3.32, and closed at $3.36. Trading volume was a total of 21.60K shares. On April 16, 2024, ACST opened at $3.33, traded as high as $3.39 and as low as $3.30, and closed at $3.35. Trading volume was a total of 7.40K shares. On April 17, 2024, ACST opened at $3.31, traded as high as $3.31 and as low as $3.16, and closed at $3.19. Trading volume was a total of 16.80K shares. On April 18, 2024, ACST opened at $3.17, traded as high as $3.17 and as low as $3.06, and closed at $3.07. Trading volume was a total of 9.70K shares.
ACST Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acasti Pharma shares, starting with a $10,000 purchase of ACST, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/22/2014 |
|
| End date: |
04/18/2024 |
|
| Start price/share: |
$484.80 |
|
| End price/share: |
$3.07 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.37% |
|
| Average Annual Total Return: |
-39.73% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$63.33 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/12/2024 | $3.41 | | 04/15/2024 | $3.36 | | 04/16/2024 | $3.35 | | 04/17/2024 | $3.19 | | 04/18/2024 | $3.07 |
|
|
Free ACST Email Alerts:
